Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-06-13 00:00:00 ET · period of report 2022-06-09 · accession 0001209191-22-036349 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-13 | 2022-06-09 | FATE | Jooss Karin | Dir | A - Grant | $0.00 | +8,650 | 9,848 | +722% | $0 |
| D | 2022-06-13 | 2022-06-09 | FATE | Jooss Karin | Dir | A - Grant | $0.00 | +11.9K | 11.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-09 | A | A | 8,650 | $0.00 | 9,848 | D | — | — | (F1) Award of restricted stock units that vest in full on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-09 | A | A | 11,893 | $0.00 | 11,893 | D | $23.48 · — to 2032-06-09 | 11,893 Common Stock | (F2) The shares subject to this option shall vest and become exercisable on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors. |